22 April 2024 in Journal of Space Safety Engineering
2 October 2024 in Journal of Space Safety Engineering
21 May 2025 in Journal of Vascular Surgery
15 April 2025 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
The aim of this study was to develop a bridge between the fields of aerospace medicine and vascular surgery, and to emphasize the need for leading experts in vascular medicine, interventional radiology, and surgery to address the critical human spaceflight research gaps highlighted by the National Aeronautics and Space Administration (NASA). A scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted on literature published between 2000 and 2024. A well-defined search strategy was employed for keyword searches across multiple databases, including PubMed, Scopus, Cochrane, Embase, the NASA Life Science Data Archive, NASA technical reports, and Google Scholar. Our review identified 125 relevant studies. These included 30 studies on general health conditions in space and wound healing, 38 addressing risk factors associated with the space environment, and 57 studies examining prevention and treatment options. These findings address NASA's identified gaps in wound care capabilities (ExMC 4.07), contribute to defining the potential list of medical conditions that could arise during deep-space missions (ExMC 4.24, Med07, Med12, Medical-101), and serve as a milestone for developing integrated exploration medical system models for missions to the Moon and Mars (Medical-501). Many of the identified NASA knowledge gaps-some of which have even been marked as closed due to a lack of research in the field-cannot be effectively addressed without bridging aerospace medicine with related disciplines, such as vascular surgery and chronic wound care.
11 October 2025 in Journal of Vascular Surgery Cases, Innovations and Techniques
MAMohamed Ahmed Abdelhalim
+4
To evaluate the early and late outcomes of patient-specific endografts with retrograde outer branches for the treatment of complex aortic aneurysms involving cranially oriented target vessels (TVs). This multicenter retrospective study incorporated both prospectively and retrospectively collected data from consecutive patients who underwent fenestrated-branched endovascular aortic repair using patient-specific endografts with retrograde branches for complex aortic aneurysms with cranially oriented TVs from August 1, 2015, to October 31, 2024. Cranial orientation was defined as an aorta-to-vessel origin angle greater than 30°. The primary outcome was retrograde branch-related target artery instability (TAI). Secondary outcomes included retrograde branch-related mortality, major adverse events, and reinterventions. Outcomes were categorized as early (within 30 days postoperatively or during hospitalization) or late events (occurring beyond 30 days after the index procedure and after hospital discharge). Twelve patients (9 male patients; median age: 77 years; interquartile range: 70.5-80 years) were analyzed. A total of 49 vessels were targeted, and 14 (28.6%) were incorporated with retrograde branches. There were no retrograde branch-related intraoperative complications. The technical success rate was 100%. The rate of early retrograde branch-related TAI was 7.1% (1/14). There were no early major adverse events. Among the 49 TVs treated, the rate of early reintervention was 4.1% (2/49), with one case being retrograde branch-related. The median follow-up was 31 months (interquartile range: 13.5-54 months). Two-year cumulative incidence of both retrograde branch-related TAI and mortality was 0.0%; however, one right renal artery incorporated with a retrograde branch occluded at postoperative 4 years. There was one late death at 2.8 years, which was not retrograde branch-related. The use of patient-specific endografts with retrograde branches is a feasible technique. It enabled the incorporation of TV with cranial orientation during the fenestrated-branched endovascular aortic repair procedure and demonstrated high technical success with low incidence of retrograde branch-related adverse events.
12 September 2025 in European Journal of Vascular and Endovascular Surgery